AVIENCE BIOMEDICAL...● IPO DETAIL GMP+₹75 STATUSListed IPOCloudTrack Every IPO AVIENCE BIOMEDICAL...● IPO DETAIL GMP+₹75 STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Avience Biomedicals Ltd

Avience Biomedicals Ltd

NSE SME · SME IPO
Listed NSE SME SME Live Chart
Issue Price
₹208
₹208
GMP (Grey Market)
+₹75
+36.06%
Est. Listing Price
₹283
Based on GMP
Min. Investment
₹124,800
1 lot × 600 shares
Subscribed
267.95x
Over-subscribed
IPO Details
Open Date
18 Jun 2026
Close Date
22 Jun 2026
Allotment
23 Jun 2026
Listing Date
25 Jun 2026
Exchange
NSE SME
Price Band
₹208
Listing Price
See chart
Allotment Status
Price Band
₹208
Per share
Face Value
₹10 per share
 
Lot Size
600 Shares
per lot
Issue Size
14,53,800 shares (agg. up to ₹30 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹124,800
1 lot
Pre-IPO Holding
40,31,256 shares
Promoters
Post-IPO Holding
54,85,056 shares
Promoters
P/E (Pre)
11.59x
 
P/E (Post)
16.56x
 
EPS (Pre)
₹17.94
 
EPS (Post)
₹12.56
 
UPI Deadline
5:00 PM on 22 Jun 2026
Mandate
GMP
+₹75
+36.06% est.
Anchor AllotmentWed, 17 Jun 2026
Basis of AllotmentTue, 23 Jun 2026
Refund InitiationWed, 24 Jun 2026
Demat CreditWed, 24 Jun 2026
Listing DayThu, 25 Jun 2026
UPI Mandate Deadline5:00 PM on 22 Jun 2026
Sale TypeFresh capital only
Net Offer to Public13,71,600 shares (agg. up to ₹29 Cr)
Market Maker Quota82,200 shares (agg. up to ₹2 Cr)
Fresh Issue Shares13,71,600 shares (agg. up to ₹29 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Avience Biomedicals Ltd IPO subscribed 267.95 times overall. Retail: 394.72x. QIB: 78.80x. NII: 597.72x. By 22 Jun 2026.
QIB
78.80x
Over
NII/HNI
597.72x
Over
Retail
394.72x
Over
Total
267.95x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
82,200
₹1.71
QIB
Over 78.80x
683,400
₹14.21
NII / HNI
Over 597.72x
207,000
₹4.31
Retail
Over 394.72x
481,200
₹10.01
Total 267.95x
1,371,600
100% ₹28.53
IPO Shares Offered
Avience Biomedicals Ltd IPO total issue size: ₹28.53 Cr. Retail: ₹10.01 Cr. QIB: ₹14.21 Cr. NII: ₹4.31 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
QIB 683,400 ₹14.21
49.83%
Market Maker 82,200 ₹1.71
5.99%
NII 207,000 ₹4.31
15.09%
Retail 481,200 ₹10.01
35.08%
Total 1,371,600 ₹28.53
100.00%
* Based on upper price band ₹208 per share
Basis of Allotment
QIB NII Retail Total
Ex. Anchor Anchor Total QIB Below ₹10L Above ₹10L Total NII
Allocation (shares) 207,000 481,200 688,200
Allotment price (₹) 208 208 208 208 208 208 208 208
No. of applications
No. of shares applied
Amount collected (₹Cr) ₹10.01 ₹10.01
Times subscribed 78.80x 597.72x 394.72x 267.95x
Shares allotted 207,000 481,200 688,200
No. of allottees
* Upper price band ₹208 · ** Anchor allotment excluded from public shares
Lot Size & Investment
Lot Size
600
Shares per Lot
Issue Price
₹208.00
Upper Band
Min Investment
₹124,800
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)21,200₹249,600
Retail (Max — 13 Lots)137,800₹1,622,400
S-HNI (Min — 14 Lots)148,400₹1,747,200
B-HNI (Min — 68 Lots)6840,800₹8,486,400
* Issue Price ₹208 × Lot Size 600 shares
IPO Schedule
Anchor
17 Jun 2026
✓ Done
IPO Open
18 Jun 2026
✓ Done
IPO Close
22 Jun 2026
✓ Done
Allotment
23 Jun 2026
✓ Done
Refunds
24 Jun 2026
✓ Done
Demat Credit
24 Jun 2026
✓ Done
Listing Day
25 Jun 2026
✓ Done
Avience Biomedicals Ltd — Live Price LIVE
₹208.00
INR · NSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹208.00 GMP: +₹75 Live Price
About Avience Biomedicals Ltd
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.In addition to manufacturing, the Company also act as distributors and traders of medical equipment.The company's manufacturing unit is situated in Noida, Uttar Pradesh.The company offers a comprehensive range of diagnostic solutions, including:Rapid Test Kits: Products like AVISURE Dengue Combo Test, Malaria Rapid Test (Pf/Pv), and AVISURE Syphilis Rapid Test.Biochemistry Analyzers and Reagents: Devices like the BS-240 Fully Auto Analyzer and reagents like AVIENBIO Albumin Kit.Molecular Diagnostics: COVID-19 detection kits, including the COVID-19 Hid RTqPCR ASSAY.Hematology Analyzers: Models like the BC-20s 3-Part Hematology Analyzer.Medical Devices: Oxygen concentrators (Oxy-5 and Oxy-10) and viral transport solutions (VTM).As of January 31, 2026, the company had 75 permanent employees and 33 contractual employeesCompetitive StrengthStrong Industry Experience and Expertise.Avience provides various diagnostic products, including rapid test kits, analyzers, hematology devices, and molecular kits.Strong distribution network across India and is growing its international footprint.Cost-Effective and Affordable Solutions.Stringent quality control processes and complies with ISO standards and regulatory approvals.
Objects of the Issue
1
Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2
Funding the working capital requirements of the Company
3
General Corporate Purposes
Avience Biomedicals Ltd Financials (Amount in ₹ Crore)
Revenue from Operations
₹10.9
31 Mar 2023
₹16.6
31 Mar 2024
₹29.5
31 Mar 2025
Profit After Tax (PAT)
₹0.8
31 Mar 2023
₹2.0
31 Mar 2024
₹5.2
31 Mar 2025
Particulars31 Mar 202531 Mar 202431 Mar 2023
Revenue from Operations 29.54 16.64 10.93
EBITDA 7.65 3.15 1.43
Profit After Tax (PAT) 5.19 1.99 0.78
Net Worth 20.60 6.07 4.08
Total Assets 43.60 25.63 10.02
Reserves & Surplus 16.57 2.79 0.79
Borrowings 13.75 7.73 2.66
EBITDA Margin (%) 24.70
PAT Margin (%) 15.86
P/BV Ratio
2.94
RoE
22.38
RoCE
16.99
RoNW
22.38
PAT Margin
15.86
EBITDA Margin
24.70
Debt/Equity
0.94
Issue Structure & Shareholding
Total Shares Offered14,53,800
Net Offer to Public13,71,600 shares (agg. up to ₹29 Cr)
Reserved for Market Maker82,200 shares (agg. up to ₹2 Cr)
Pre-Issue Promoter Holding40,31,256 shares
Post-Issue Promoter Holding54,85,056 shares
P/BV Ratio2.94
RoE22.38
RoCE16.99
Debt / Equity0.94
Script CodeN/A
Registrar & Lead Managers
IPO Registrar
Skyline Financial Services Pvt.Ltd
Check Allotment
Book Running Lead Managers
Fintellectual Corporate Advisors Pvt.Ltd
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Avience Biomedicals Ltd IPO subscribed?

Avience Biomedicals Ltd IPO is subscribed 267.95 times by Jun 22, 2026. Retail: 394.72x. QIB: 78.80x. NII: 597.72x.

Investor CategorySubscription
Qualified Institutional (QIB)78.80x
Non Institutional (NII/HNI)597.72x
Retail Individual394.72x
Total Subscription267.95x
What is Avience Biomedicals Ltd IPO retail subscription status?

The Avience Biomedicals Ltd IPO retail category is subscribed 394.72 times as of 22 Jun 2026. The retail portion is oversubscribed.

How to subscribe Avience Biomedicals Ltd IPO?

Subscribe via your broker app using ASBA or UPI. Opens 18 Jun 2026 and closes 22 Jun 2026. Min investment: ₹124,800 (1 lot = 600 shares). UPI mandate: 5:00 PM on 22 Jun 2026.

How many times Avience Biomedicals Ltd IPO subscribed?

The Avience Biomedicals Ltd IPO subscribed 267.95x overall. QIB: 78.80x, NII: 597.72x, Retail: 394.72x. Applications: from NSE/BSE.

How to check Avience Biomedicals Ltd IPO allotment?

Check allotment on the registrar website (Skyline Financial Services Pvt.Ltd) at https://www.skylinerta.com/ipo.php. Enter your PAN, application number or DP/Client ID. Allotment date: 23 Jun 2026. Refunds: on 24 Jun 2026.

When Avience Biomedicals Ltd IPO will be listed?

The Avience Biomedicals Ltd IPO listing date is 25 Jun 2026, Thursday. Listed on: NSE SME. Issue price: ₹208. Estimated listing: ₹283. GMP: +₹75.

When Avience Biomedicals Ltd IPO close?

The Avience Biomedicals Ltd IPO closes on 22 Jun 2026, Monday. UPI mandate: 5:00 PM on 22 Jun 2026. Allotment: 23 Jun 2026. Listing: 25 Jun 2026.